MedPath

Effect of diet therapy in treatment of women with polycystic ovary syndrome

Phase 3
Conditions
Polycystic ovary syndrome.
Polycystic ovarian syndrome
E28.2
Registration Number
IRCT201601055623N66
Lead Sponsor
Vice chancellor for research, Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Patients with PCOS according to Rotterdam criteria
Aged 18 to 40 years

Exclusion Criteria

Pregnant during the intervention
Hyperplasia
Androgen secreting tumors
Hyperprolactinemia
Thyroid dysfunction
Diabetes or impaired glucose tolerance

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anti-Mullerian Hormone. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath